Study on the Post-Harvest Physical and Chemical Characteristics of Apricot (Prunus Armeniaca L.) in Peshawar

Physical and chemical properties of four apricot varieties viz., Travett, Palumella, Charmaghz and Badami, fruits were presented in this study. Information about these properties is very important for understanding the behavior of the product during the post harvest operations such as harvesting, transporting, sorting, packing and storage processes. The mean value of fruit length, width, thickness, weight, volume, pulp weight,  kernel weight were established between 40.36-31.19mm, 36.17-26.76mm, 32,20-26.16mm, 30.63-23.83g, 29.53-22.10cm³, 29.91-22.20g, 2.63-1.63g, respectively. The chemical properties which include TSS was found in range of 11.27-9.43, total sugar 11.21-8.75%, reducing sugar 2.43-1.65%, non-reducing sugar 7.35-6.32 and titratable acidity 1.60-1.12%. Therefore, based on physical (quality) properties varieties Palumella and Charmaghz were found superior, whereas in chemical properties varieties Badami and Travett were the best among the tested varieties.   Keywords: Apricot (Prunus armeniaca L), Apricot, physical and chemical properties, Pakistan

Adopting Scenario-Based approach to solve optimal reactive power Dispatch problem with integration of wind and solar energy using improved Marine predator algorithm

The penetration of renewable energy resources into electric power networks has been increased considerably to reduce the dependence of conventional energy resources, reducing the generation cost and greenhouse emissions. The wind and photovoltaic (PV) based systems are the most applied technologies in electrical systems compared to other technologies of renewable energy resources. However, there are some complications and challenges to incorporating these resources due to their stochastic nature, intermittency, and variability of output powers. Therefore, solving the optimal reactive power dispatch (ORPD) problem with considering the uncertainties of renewable energy resources is a challenging task. Application of the Marine Predators Algorithm (MPA) for solving complex multimodal and non-linear problems such as ORPD under system uncertainties may cause entrapment into local optima and suffer from stagnation. The aim of this paper is to solve the ORPD problem under deterministic and probabilistic states of the system using an improved marine predator algorithm (IMPA). The IMPA is based on enhancing the exploitation phase of the conventional MPA. The proposed enhancement is based on updating the locations of the populations in spiral orientation around the sorted populations in the first iteration process, while in the final stage, the locations of the populations are updated their locations in adaptive steps closed to the best population only. The scenario-based approach is utilized for uncertainties representation where a set of scenarios are generated with the combination of uncertainties the load demands and power of the renewable resources. The proposed algorithm is validated and tested on the IEEE 30-bus system as well as the captured results are compared with those outcomes from the state-of-the-art algorithms. A computational study shows the superiority of the proposed algorithm over the other reported algorithms

Simulation-optimization of Tarbela Reservoir operation to enhance multiple benefits and to achieve sustainable development goals

Pakistan’s agriculture and economy rely heavily on the Tarbela Reservoir. The present storage capacity of Tarbela is 8.2 BCM and it has been depleted by more than 40% due to sedimentation since 1976. It also has had a 0.94 percent (0.134 BCM) decrease in gross reservoir capacity every year. Historically, the amount of sediment trapped in the Tarbela Reservoir during the period 1976–2020 was 198.5 million tonnes annually. Based on the current operation by the Water and Power Development Authority (WAPDA), the delta is expected to extend to 2.41 km from the dam in 2035. The reservoir will become a run-of-the-river reservoir with a gross storage capacity of 2.87 BCM. This rapid loss of storage capacity will significantly impact reservoir benefits while also putting turbine performance at risk due to abrasion. Slowing the sediment deposition phenomena by a flexible operational strategy is a worthwhile aim from the dam manager’s viewpoint to achieve Sustainable Development Goals (i.e., poverty and hunger alleviation, clean affordable energy, protecting ecosystem etc.). Therefore, for the safe and long-term operation of the turbines, the existing Standard Operating Procedures (SOPs) adopted by WAPDA need to be appraised to delineate their impact on future optimized operations. The aspect of considering static SOPs on the whole period of reservoir operation has not been attempted earlier. The Tarbela Reservoir was selected as a case study to enhance the existing reservoir operation. The methodology relies upon the use of a 1-D sediment transport model in HEC-RAS to study the impact of the operational strategy on sedimentation. In conjunction, the existing reservoir operation of Tarbela was modelled in HEC-ResSim using its physical, operational, and 10-daily time-series data for simulation of releases and hydropower benefits based on a revised elevation-capacity curve for sedimentation. After calibration and validation, the model was applied to predict future reservoir operation impacts on a 5-year basis from 2025 to 2035 for determining storage capacity, irrigation releases, power production and energy generation. It was predicted that as the storage capacity of the reservoir is depleted (by application of the WAPDA current SOPs in future years), the irrigation releases would be increased in the Kharif season (April–September) by 7% and decreased by 50% in the Rabi season (October–March) with a corresponding increase in power generation by 4% and decrease by 37%, respectively, and the average annual energy generation would be decreased by 6.5%. The results showed that a gradual increase in the minimum operating level will slow down delta movement but it will reduce irrigation releases at times of high demand. The findings may assist water managers to improve the Tarbela Reservoir operation to achieve sustainable development goals and to attain societal future benefits

Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: A descriptive study

<p>Abstract</p> <p>Background</p> <p>This study was conducted to evaluate drug resistance amongst bacteremic isolates of febrile neutropenic patients with particular emphasis on emergence of carbapenem resistant Gram negative bacteria and vancomycin resistant <it>Enterococcus </it>species.</p> <p>Methods</p> <p>A descriptive study was performed by reviewing the blood culture reports from febrile neutropenic patients during the two study periods i.e., 1999–00 and 2001–06. Blood cultures were performed using BACTEC 9240 automated system. Isolates were identified and antibiotic sensitivities were done using standard microbiological procedures.</p> <p>Results</p> <p>Seven twenty six febrile neutropenic patients were admitted during the study period. A total of 5840 blood cultures were received, off these 1048 (18%) were culture positive. Amongst these, 557 (53%) grew Gram positive bacteria, 442 (42%) grew Gram negative bacteria, 43 (4%) fungi and 6 (1%) anaerobes. Sixty (5.7%) out of 1048 positive blood cultures were polymicrobial. In the Gram negative bacteria, <it>Enterobacteriaceae </it>was the predominant group; <it>E. coli </it>was the most frequently isolated organism in both study periods. Amongst non- Enterobacteriaceae group, <it>Pseudomonas aeruginosa </it>was the commonest organism isolated during first study period followed by <it>Acinetobacter </it>spp. However, during the second period <it>Acinetobacter </it>species was the most frequent pathogen.</p> <p><it>Enterobacteriaceae </it>group showed higher statistically significant resistance in the second study period against ceftriaxone, quinolone and piperacillin/tazobactam, whilst no resistance observed against imipenem/meropenem. The susceptibility pattern of <it>Acinetobacter </it>species shifted from sensitive to highly resistant one with significant p values against ceftriaxone, quinolone, piperacillin/tazobactam and imipenem/meropenem. Amongst Gram positive bacteria, MRSA isolation rate remained static, vancomycin resistant <it>Enterococcus </it>species emerged in second study period while no <it>Staphylococcus </it>species resistant to vancomycin was noted.</p> <p>Conclusion</p> <p>This rising trend of highly resistant organisms stresses the increasing importance of continuous surveillance system and stewardship of antibiotics as strategies in the overall management of patients with febrile neutropenia.</p

Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial

Background Post-partum haemorrhage is the leading cause of maternal death worldwide. Early administration of tranexamic acid reduces deaths due to bleeding in trauma patients. We aimed to assess the effects of early administration of tranexamic acid on death, hysterectomy, and other relevant outcomes in women with post-partum haemorrhage. Methods In this randomised, double-blind, placebo-controlled trial, we recruited women aged 16 years and older with a clinical diagnosis of post-partum haemorrhage after a vaginal birth or caesarean section from 193 hospitals in 21 countries. We randomly assigned women to receive either 1 g intravenous tranexamic acid or matching placebo in addition to usual care. If bleeding continued after 30 min, or stopped and restarted within 24 h of the first dose, a second dose of 1 g of tranexamic acid or placebo could be given. Patients were assigned by selection of a numbered treatment pack from a box containing eight numbered packs that were identical apart from the pack number. Participants, care givers, and those assessing outcomes were masked to allocation. We originally planned to enrol 15 000 women with a composite primary endpoint of death from all-causes or hysterectomy within 42 days of giving birth. However, during the trial it became apparent that the decision to conduct a hysterectomy was often made at the same time as randomisation. Although tranexamic acid could influence the risk of death in these cases, it could not affect the risk of hysterectomy. We therefore increased the sample size from 15 000 to 20 000 women in order to estimate the effect of tranexamic acid on the risk of death from post-partum haemorrhage. All analyses were done on an intention-to-treat basis. This trial is registered with ISRCTN76912190 (Dec 8, 2008); ClinicalTrials.gov, number NCT00872469; and PACTR201007000192283. Findings Between March, 2010, and April, 2016, 20 060 women were enrolled and randomly assigned to receive tranexamic acid (n=10 051) or placebo (n=10 009), of whom 10 036 and 9985, respectively, were included in the analysis. Death due to bleeding was significantly reduced in women given tranexamic acid (155 [1·5%] of 10 036 patients vs 191 [1·9%] of 9985 in the placebo group, risk ratio [RR] 0·81, 95% CI 0·65–1·00; p=0·045), especially in women given treatment within 3 h of giving birth (89 [1·2%] in the tranexamic acid group vs 127 [1·7%] in the placebo group, RR 0·69, 95% CI 0·52–0·91; p=0·008). All other causes of death did not differ significantly by group. Hysterectomy was not reduced with tranexamic acid (358 [3·6%] patients in the tranexamic acid group vs 351 [3·5%] in the placebo group, RR 1·02, 95% CI 0·88–1·07; p=0·84). The composite primary endpoint of death from all causes or hysterectomy was not reduced with tranexamic acid (534 [5·3%] deaths or hysterectomies in the tranexamic acid group vs 546 [5·5%] in the placebo group, RR 0·97, 95% CI 0·87-1·09; p=0·65). Adverse events (including thromboembolic events) did not differ significantly in the tranexamic acid versus placebo group. Interpretation Tranexamic acid reduces death due to bleeding in women with post-partum haemorrhage with no adverse effects. When used as a treatment for postpartum haemorrhage, tranexamic acid should be given as soon as possible after bleeding onset. Funding London School of Hygiene & Tropical Medicine, Pfizer, UK Department of Health, Wellcome Trust, and Bill & Melinda Gates Foundation

Outcomes of obstructed abdominal wall hernia: results from the UK national small bowel obstruction audit

Background: Abdominal wall hernia is a common surgical condition. Patients may present in an emergency with bowel obstruction, incarceration or strangulation. Small bowel obstruction (SBO) is a serious surgical condition associated with significant morbidity. The aim of this study was to describe current management and outcomes of patients with obstructed hernia in the UK as identified in the National Audit of Small Bowel Obstruction (NASBO). Methods: NASBO collated data on adults treated for SBO at 131 UK hospitals between January and March 2017. Those with obstruction due to abdominal wall hernia were included in this study. Demographics, co-morbidity, imaging, operative treatment, and in-hospital outcomes were recorded. Modelling for factors associated with mortality and complications was undertaken using Cox proportional hazards and multivariable regression modelling. Results: NASBO included 2341 patients, of whom 415 (17·7 per cent) had SBO due to hernia. Surgery was performed in 312 (75·2 per cent) of the 415 patients; small bowel resection was required in 198 (63·5 per cent) of these operations. Non-operative management was reported in 35 (54 per cent) of 65 patients with a parastomal hernia and in 34 (32·1 per cent) of 106 patients with an incisional hernia. The in-hospital mortality rate was 9·4 per cent (39 of 415), and was highest in patients with a groin hernia (11·1 per cent, 17 of 153). Complications were common, including lower respiratory tract infection in 16·3 per cent of patients with a groin hernia. Increased age was associated with an increased risk of death (hazard ratio 1·05, 95 per cent c.i. 1·01 to 1·10; P = 0·009) and complications (odds ratio 1·05, 95 per cent c.i. 1·02 to 1·09; P = 0·001). Conclusion: NASBO has highlighted poor outcomes for patients with SBO due to hernia, highlighting the need for quality improvement initiatives in this group

The global burden of cancer attributable to risk factors, 2010-19 : a systematic analysis for the Global Burden of Disease Study 2019

Background Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. Methods The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk-outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. Findings Globally, in 2019, the risk factors included in this analysis accounted for 4.45 million (95% uncertainty interval 4.01-4.94) deaths and 105 million (95.0-116) DALYs for both sexes combined, representing 44.4% (41.3-48.4) of all cancer deaths and 42.0% (39.1-45.6) of all DALYs. There were 2.88 million (2.60-3.18) risk-attributable cancer deaths in males (50.6% [47.8-54.1] of all male cancer deaths) and 1.58 million (1.36-1.84) risk-attributable cancer deaths in females (36.3% [32.5-41.3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20.4% (12.6-28.4) and DALYs by 16.8% (8.8-25.0), with the greatest percentage increase in metabolic risks (34.7% [27.9-42.8] and 33.3% [25.8-42.0]). Interpretation The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019. Reducing exposure to these modifiable risk factors would decrease cancer mortality and DALY rates worldwide, and policies should be tailored appropriately to local cancer risk factor burden. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.Peer reviewe

National prospective cohort study of the burden of acute small bowel obstruction

Background Small bowel obstruction is a common surgical emergency, and is associated with high levels of morbidity and mortality across the world. The literature provides little information on the conservatively managed group. The aim of this study was to describe the burden of small bowel obstruction in the UK. Methods This prospective cohort study was conducted in 131 acute hospitals in the UK between January and April 2017, delivered by trainee research collaboratives. Adult patients with a diagnosis of mechanical small bowel obstruction were included. The primary outcome was in‐hospital mortality. Secondary outcomes included complications, unplanned intensive care admission and readmission within 30 days of discharge. Practice measures, including use of radiological investigations, water soluble contrast, operative and nutritional interventions, were collected. Results Of 2341 patients identified, 693 (29·6 per cent) underwent immediate surgery (within 24 h of admission), 500 (21·4 per cent) had delayed surgery after initial conservative management, and 1148 (49·0 per cent) were managed non‐operatively. The mortality rate was 6·6 per cent (6·4 per cent for non‐operative management, 6·8 per cent for immediate surgery, 6·8 per cent for delayed surgery; P = 0·911). The major complication rate was 14·4 per cent overall, affecting 19·0 per cent in the immediate surgery, 23·6 per cent in the delayed surgery and 7·7 per cent in the non‐operative management groups (P < 0·001). Cox regression found hernia or malignant aetiology and malnutrition to be associated with higher rates of death. Malignant aetiology, operative intervention, acute kidney injury and malnutrition were associated with increased risk of major complication. Conclusion Small bowel obstruction represents a significant healthcare burden. Patient‐level factors such as timing of surgery, acute kidney injury and nutritional status are factors that might be modified to improve outcomes